In this interactive CE activity, experts review diagnostic strategies to differentiate EGPA from vasculitic/eosinophilic conditions with similar clinical presentations. Faculty will also highlight the clinical evidence for current and emerging treatment options, discussing evidence-based treatment strategies to prevent EGPA relapse and minimize glucocorticoid toxicity. Through these insights, this program aims to enhance clinicians’ ability to manage EGPA effectively, improving patient outcomes and quality of life.
- Provider:Vindico Medical Education, LLC
- Activity Link: https://www.healio.com/cme/rheumcme/immunology-and-biologics/20240731/egpa-evidence-based-recommendations-for-enhanced-patient-outcomes/overview
- Start Date: 2024-07-31 05:00:00
- End Date: 2024-07-31 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: Source: AstraZeneca Pharmaceuticals - Amount: 57197.5 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest